Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARR
The company said its diagnostics business crossed an annualised revenue run rate of more than Rs 600 crore during the year, growing over 40 per cent year-on-year while sustaining double-digit Ebitda margins.
The Economic Times ·